Clinical Trials

Showing trials with last updates posted in 2024.

NCT03510689 | COMPLETED
79 participants

Genetics and Heart Health After Cancer Therapy

Study Type:
OBSERVATIONAL
Last Updated:
2024-10-16
Start Date:
2017-12-05
Completion:
2022-05-31
Conditions
  • Breast Cancer
  • Hereditary Breast/Ovarian Cancer (brca1, Brca2)
  • Heart Diseases
  • Drug-Induced Cardiomyopathy
Interventions
  • DIAGNOSTIC_TEST
  • OTHER
No Results Yet
NCT03274466 | COMPLETED | NA
294 participants

Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty

Study Type:
INTERVENTIONAL
Last Updated:
2024-10-16
Start Date:
2017-12-05
Completion:
2019-11-27
Conditions
  • Surgical Wound
  • Revision Total Knee Arthroplasty
  • Wounds and Injuries
  • Joint Disease
  • Musculoskeletal Disease
  • Prosthesis-Related Infections
  • Infection
  • Postoperative Complications
  • Pathologic Processes
Interventions
  • DEVICE
NCT03238053 | WITHDRAWN | NA
0 participants

Laser Treatment of Genito-urinary Syndrome in Women

Study Type:
INTERVENTIONAL
Last Updated:
2024-10-16
Start Date:
2022-10-01
Completion:
2025-12-31
Conditions
  • Laser-Induced Scar
  • Breast Cancer
  • Endometrial Cancer
  • Menopause
  • Vaginal Atrophy
  • Bladder, Overactive
Interventions
  • PROCEDURE
  • DEVICE
No Results Yet
NCT02927964 | COMPLETED | PHASE1/PHASE2
21 participants

TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2024-10-16
Start Date:
2016-11-07
Completion:
2023-05-18
Conditions
  • Grade 1 Follicular Lymphoma
  • Grade 2 Follicular Lymphoma
  • Grade 3a Follicular Lymphoma
  • Recurrent Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Mantle Cell Lymphoma
  • Marginal Zone Lymphoma
Interventions
  • DRUG
  • RADIATION
NCT02097225 | TERMINATED | PHASE1
22 participants

Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2024-10-16
Start Date:
2014-05-29
Completion:
2019-03-31
Conditions
  • BRAF V600E Mutation Present
  • BRAF V600K Mutation Present
  • Metastatic Malignant Solid Neoplasm
  • Metastatic Melanoma
  • Stage III Cutaneous Melanoma AJCC v7
  • Stage IIIA Cutaneous Melanoma AJCC v7
  • Stage IIIB Cutaneous Melanoma AJCC v7
  • Stage IIIC Cutaneous Melanoma AJCC v7
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Unresectable Solid Neoplasm
Interventions
  • DRUG
  • OTHER
Previous
Sorted by latest updates
Next
Showing 40 trials per page